Overview

Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
Single-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy and safety study using the Allergen BioCube (ABC).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
3E Therapeutics Corporation
Collaborator:
ORA, Inc.
Treatments:
Pharmaceutical Solutions